Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 428 across all filing types
Latest filing 2023-01-05 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2023-01-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate submitted to the National Stock Exchange of India for the quarter ended December 31, 2022, pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. It is a certificate from the Registrar and Share Transfer Agent confirming compliance related to shareholding and dematerialisation status. The document is short (2478 characters) and primarily serves as a regulatory compliance attestation rather than a financial report or detailed filing. It does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory announcements that do not fit other specific categories.
2023-01-05 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the trading window closure period related to the upcoming declaration of the company's un-audited financial results for the quarter ending December 31, 2022. The document does not contain any financial data, results, or detailed report but is an announcement related to insider trading compliance and trading restrictions. It is short (1555 characters) and serves as a regulatory notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2022-12-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the publication of a corrigendum to the Extra-Ordinary General Meeting (EGM) notice. It references compliance with SEBI regulations and mentions newspaper advertisements related to the EGM notice. There is no indication of financial statements, audit results, earnings data, or detailed management discussion. The document is primarily an announcement about the publication of a corrigendum notice for an EGM, which is a regulatory announcement related to shareholder meetings but not the meeting materials themselves or voting results. The document length is about 15,000 characters, but the content is focused on the corrigendum publication, not the full EGM notice or results. Therefore, this fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document rather than a specific report or meeting material.
2022-12-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the publication of a corrigendum to the Extra-Ordinary General Meeting (EGM) notice. It references compliance with SEBI (Listing Obligation and Disclosure Requirement) Regulations and mentions newspaper advertisements related to the EGM notice. There is no indication of financial statements, audit results, earnings data, or detailed management discussion. The document is primarily an announcement about the publication of a corrigendum notice for an EGM, which is a regulatory disclosure rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-12-24 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited, announcing that Vaishali Pharma Limited has signed a unique partnership agreement with Jark Pharma for Ayurvedic Products and Herbal Cosmetics. It includes a press release detailing the partnership, product ranges, and company background. There are no financial statements, regulatory certifications, voting results, or management changes. The document is an announcement of a business partnership and strategic collaboration, not a financial report, earnings release, or regulatory filing. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under a general regulatory announcement category that covers miscellaneous filings that do not fit other specific categories.
2022-12-21 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.